15.1 Major Depressive Disorder, Antidepressant Pharmacotherapy, Bipolar Affective Disorder, and Perinatal Mental Health

Key Takeaways

  • For a DSM-5 major depressive episode, at least five of nine symptoms are present over the same two-week period and include depressed mood or loss of interest or pleasure. Assess function, suicidality, possible bipolarity and other explanations.

  • Discuss psychological and medication options according to severity and preference. When starting an antidepressant, explain delayed benefit, adverse effects and review. Continue after remission where appropriate, assess relapse risk and taper gradually when stopping.

  • Clonus and hyperreflexia after a relevant serotonergic exposure support serotonin toxicity. Stop causative medicines, stabilise physiology, reduce agitation and muscle activity and cool if hyperthermic. Severe cases need urgent critical care and toxicology input.

  • A manic episode is sufficient for bipolar I when other causes are excluded. Bipolar II requires hypomania and major depression without mania. Lithium requires planned timed levels and renal, thyroid and calcium monitoring.

  • Suspected postpartum psychosis requires immediate emergency mental health assessment, continuous support and an infant safety plan. Arrange admission through the available Irish pathway when needed.

Last updated: November 2026

Depressive episodes and initial assessment

A depressive episode is a sustained change in mood or interest accompanied by other symptoms and clinically important distress or impairment. In DSM-5, at least five of the following nine symptoms occur in the same two-week period, with at least one of depressed mood or loss of interest or pleasure:

  1. Depressed mood for most of the day, nearly every day.
  2. Marked loss of interest or pleasure.
  3. Significant changes in weight or appetite.
  4. Insomnia or hypersomnia.
  5. Observable psychomotor agitation or slowing.
  6. Low energy or fatigue.
  7. Worthlessness or excessive or inappropriate guilt.
  8. Poor concentration or indecisiveness.
  9. Recurrent thoughts of death or suicide, or suicidal behaviour.

The WHO ICD-11 clinical descriptions similarly recognise at least two weeks of characteristic symptoms with a core affective symptom, and explicitly list hopelessness as a separate symptom. Identify which classification a numerical question uses. Assess severity through symptom intensity, impairment, course, safety and psychosis. A person with fewer but severe symptoms may need urgent help.

Ask directly about self-harm, suicidal thoughts, intention, available means and support. Ask about previous episodes of unusually elevated or irritable mood with increased energy and less need for sleep. Review alcohol, other substances, medication and medical causes according to the presentation. In severe depression, psychotic symptoms can include fixed guilt or poverty beliefs. Psychosis between mood episodes changes the differential. Urgently assess people with imminent risk, psychosis with safety concerns or severe self-neglect.

Plan treatment and review

For less severe depression, discuss options such as guided self-help and psychological intervention, guided by preference. NICE NG222 does not routinely offer antidepressants first for less severe depression unless preferred. For more severe depression, options include an antidepressant, individual psychological treatment or both. Specialist assessment is appropriate for psychotic depression. Discuss previous benefit, adverse effects, interactions, comorbidities and overdose safety.

SSRIs inhibit serotonin reuptake and are a common first choice if medication is appropriate. For adult depression, an Irish sertraline SmPC starts at 50 mg daily, with adjustments at least a week apart to a maximum of 200 mg daily. Irish Lexapro usual adult dosing is 10 mg daily, up to 20 mg where appropriate. For adults over 65 its starting dose is 5 mg and maximum 10 mg daily. Escitalopram can prolong QT. Check the indication, product, other QT-prolonging medicines and patient-specific risk. A dose used for depression does not necessarily apply to panic disorder or other conditions.

  • Set expectations: Benefit can take several weeks. Explain possible nausea, sleep changes, agitation and sexual adverse effects. Ask about new or worsening suicidal thoughts, particularly after starting or changing treatment. NICE usually recommends review within two weeks, or after one week for ages 18–25 or particular suicide risk. Provide a plan for urgent help if symptoms worsen.
  • Check risks: SSRIs can contribute to hyponatraemia, especially in susceptible older adults or with other medicines such as diuretics. Review electrolytes when clinically indicated. Check bleeding risk with NSAIDs, antiplatelets or anticoagulants and consider gastroprotection where appropriate.
  • Prevent relapse: Discuss that treatment may need to continue for at least six months after remission. For higher recurrence risk, agree a longer plan and review it regularly, considering prior episodes, residual symptoms and adverse effects.
  • Taper with the patient: Reduce in stages with tolerable intervals and smaller steps as needed. Withdrawal can include dizziness, sleep disruption and electric shock sensations. Paroxetine and venlafaxine have greater withdrawal risk. Tailor the taper to half-life, history and symptoms. Symptoms emerging very soon after reduction may be withdrawal. Check both the timeline and the person's clinical state.

Serotonin toxicity

Suspect serotonin toxicity with relevant exposure and a compatible pattern of neuromuscular excitation, autonomic disturbance and altered mental state. Review recent starts, dose increases, overdoses and interactions. Examples include tramadol added to an SSRI, serotonergic drugs combined with an MAOI, and interactions involving linezolid or intravenous methylene blue. Check product-specific interaction and washout rules. A long half-life can prolong risk after stopping fluoxetine.

Hunter decision rules

The original rule was derived in an overdose service. Apply it in clinical context with a credible serotonergic exposure and assess competing causes. Its alternative patterns are:

  • Spontaneous clonus.
  • Inducible clonus with either agitation or diaphoresis.
  • Ocular clonus with either agitation or diaphoresis.
  • Tremor with hyperreflexia.
  • Hypertonia and temperature above 38 °C, with ocular or inducible clonus.

Hyperreflexia and clonus are especially informative, although severe rigidity can make them difficult to elicit. The differential includes neuroleptic malignant syndrome, anticholinergic or sympathomimetic toxicity, infection and other causes of a hyperthermic patient with altered consciousness. Check changes in dopamine-blocking drugs and the time course. Measure temperature and assess for rhabdomyolysis and organ complications in severe toxicity.

Immediate management

Stop the implicated medicines. Stabilise airway, breathing and circulation and monitor temperature, ECG and perfusion. Give IV fluid according to physiological needs and use titrated benzodiazepines to reduce agitation and muscle activity with appropriate monitoring. Begin active cooling when hyperthermia is clinically significant. Antipyretics do not address heat production from sustained muscle activity.

In severe or rapidly progressive toxicity, obtain emergency critical care and toxicology advice. Marked rigidity and rising temperature despite initial measures may require airway control, ventilation and non-depolarising paralysis with aggressive cooling. Some toxicology services consider enteral cyproheptadine in selected cases. Evidence of benefit is limited and cooling and organ support take priority.

Worked distinction: New tramadol in a patient taking sertraline, followed by diaphoresis, agitation and spontaneous clonus, supports serotonin toxicity. Stop both drugs and start assessment and support regardless of whether a serotonin antagonist is available.

Bipolar disorder, episodes and long-term care

Bipolar I involves at least one manic episode. Major depression can occur but is not required. Bipolar II includes hypomania and major depression without a history of mania. Exclude a better explanation such as a substance, medication effect or medical illness. Obtain collateral history when possible.

FeatureManiaHypomania
SymptomsElevated, expansive or irritable mood with increased energy or activity. Look for decreased need for sleep, grandiosity, talkativeness, flight of ideas, distractibility or risky activity.A similar change in mood and energy, with observable change from baseline.
DSM-5 duration and impairmentAt least a week, or a shorter period if hospitalisation is necessary. Causes marked impairment, needs hospitalisation or includes psychosis.At least four consecutive days. No marked impairment, need for hospitalisation or psychosis.

For DSM-5 mania, at least three associated symptoms are required, or four when mood is only irritable. Feeling rested after two hours of sleep with unusually ambitious plans differs from feeling exhausted and unable to sleep. Document function, time course and psychotic symptoms, and ask about medication, stimulants and alcohol.

Treat the episode and prevent relapse

Acute mania needs prompt specialist assessment, with emergency care if risk is significant. Consider stopping antidepressants when mania emerges, with the acute regimen and manner of stopping decided clinically. NICE CG185 lists haloperidol, olanzapine, quetiapine and risperidone as acute options. Choose by past response, comorbidities and adverse effects, and check Irish authorisation and dosing. Use short-term sedative medication only when appropriate with monitoring. Bipolar depression requires a separate specialist treatment plan. Avoid assuming that the unipolar antidepressant pathway applies.

Lithium is a first-line long-term option under NICE CG185. Other drugs and structured psychosocial treatment may be appropriate. Valproate is contraindicated for bipolar disorder during pregnancy. In people of childbearing potential it requires specialist oversight and all applicable pregnancy prevention conditions. HPRA guidance for men includes specialist review and discussion of effective contraception for the patient and partner during therapy and for at least three months after stopping. The EMA June 2026 review found inconsistent evidence for a causal paternal effect and retained the precautions.

Irish lithium monitoring

Lithium has a narrow therapeutic range. Before starting, discuss benefit, monitoring and reproductive plans. The HSE checklist includes weight/BMI, renal function and electrolytes, thyroid function, adjusted calcium, FBC and ECG assessment. Check pregnancy when relevant. Plan ongoing treatment with the specialist and document the product and target.

Timing in the HSE clinician checklistMonitoring
Initiation, dose change or a relevant medicine changeCheck a 12-hour level after about 5–7 days and repeat during titration as indicated.
Every three months in the checklistTimed lithium level, urea, creatinine, eGFR, sodium and potassium.
Every six monthsTSH, free T4 and adjusted calcium.

The HSE patient booklet describes an individually scheduled interval for lithium levels, often three to six months when stable. Increase surveillance when unwell, renal function changes or potential interactions arise. At a planned 12-hour sample, a recorded 20:00 dose corresponds to 08:00 sampling. Verify product and timing if interpreting a result because the Irish Priadel SmPC differentiates 12- and 24-hour values. NICE CG185 targets 0.6–0.8 mmol/L initially, with consideration of 0.8–1.0 mmol/L in selected relapse or persistent symptom situations under specialist care. Lithium can contribute to polyuria, renal impairment, hypothyroidism and hypercalcaemia.

Suspected toxicity

Vomiting, diarrhoea, coarse tremor, ataxia, dysarthria, confusion or reduced alertness in a lithium-treated patient require urgent assessment. Dehydration and medicines such as NSAIDs, ACE inhibitors, ARBs or thiazides can raise risk. A symptomatic patient needs an urgent level and repeat measurements. Do not wait for the planned trough time. The level is interpreted alongside renal function, exposure type and clinical findings.

Withhold lithium and interacting medicines, assess airway and circulation, obtain ECG and urgent electrolytes, renal function and lithium, and correct volume depletion with reassessed isotonic saline where appropriate. Contact toxicology and nephrology early when indicated. EXTRIP recommends extracorporeal treatment for impaired kidney function with lithium above 4.0 mmol/L, or reduced consciousness, seizures or life-threatening dysrhythmia attributable to poisoning regardless of level. It suggests consideration for lithium above 5.0 mmol/L, significant confusion, or an estimated time above 36 hours to reach below 1.0 mmol/L with optimal treatment. Serial levels, neurological examination and specialist advice matter because severity can vary at the same concentration.

Perinatal mood disorders and postpartum psychosis

Ask about mood, sleep, functioning, support, domestic safety and thoughts of self-harm. Assess prior severe mental illness, especially bipolar disorder or postpartum psychosis. Arrange proactive planning in pregnancy and early postpartum follow-up when risk is elevated.

PresentationDistinguishing patternInitial decision
Postpartum bluesTransient tearfulness, irritability or mood fluctuation in the first days after birth, usually resolving within about two weeksOffer support and rest where possible. Reassess if symptoms persist, worsen or affect safety or function.
Perinatal depressionPersistent low mood or loss of interest with impairment during pregnancy or in the first postnatal year. Can include guilt, anxiety, fatigue or difficulty bonding.Assess clinically, including risk to mother and infant. Offer psychological care and consider medication or specialist referral according to severity and preferences.
Postpartum psychosisSudden mania, marked insomnia or reduced need for sleep, disorganisation, perplexity, delusions or hallucinations, often in the first two weeksRequires immediate emergency mental health assessment, close supervision and a plan to keep mother and infant safe.

The Edinburgh Postnatal Depression Scale can support discussion and identification. Interpret scores in the service's pathway alongside a clinical interview. A self-harm response requires direct assessment irrespective of the total. Clarify the nature of intrusive fears and assess insight, intention and belief. A distressing unwanted thought with preserved insight differs from a fixed belief commanding action, but both warrant assessment according to risk.

Tailor treatment to the person and infant

Psychological treatment and support can be useful. For more severe or persistent depression, discuss antidepressants and previous treatment response and involve perinatal specialists where appropriate. The UK Specialist Pharmacy Service identifies sertraline and paroxetine as preferred SSRIs during breastfeeding for healthy term infants because exposure is generally low. Continuing an effective medicine may be appropriate. Review maternal benefit, potential infant effects, prematurity or illness and the effects of an untreated episode.

When postpartum psychosis is suspected

Seek immediate emergency psychiatric assessment, preferably with specialist perinatal input where available. Assess medical and neurological causes in parallel when indicated. Ensure the infant is with a safe adult and the mother has close support. Do not leave them alone together while there is concern for safety. Arrange admission through the available maternity and mental health pathways when needed. A specialist mother and baby unit can preserve the relationship where available. Irish HSE emergency arrangements can involve admission to a general psychiatric ward, with a care plan for the infant. The national unit was still in development in the HSE's 2026 update.

The specialist team selects medication and the admission plan. Acute treatment can include an antipsychotic, with decisions on a mood stabiliser or ECT depending on diagnosis, severity, previous response and clinical needs. A patient with mania, hallucinations and dangerous beliefs about the infant cannot safely be managed by reassurance or discharge on antidepressant monotherapy.

Loading diagram...
Clinical Pathway for Acute Perinatal and Mood Presentations
Test Your Knowledge

A 34-year-old woman with a history of recurrent depression treated with sertraline 100 mg daily presents to the emergency department with severe agitation, shivering, and profuse sweating. Three days ago, her general practitioner prescribed oral tramadol 50 mg three times daily for severe acute back pain. On physical examination, her temperature is 39.2°C, heart rate 124 beats/min, blood pressure 156/94 mmHg, and respiratory rate 22 breaths/min. She is diaphoretic, disoriented, and visibly agitated. Neurological examination reveals bilateral spontaneous ankle clonus, ocular clonus on lateral gaze, generalized hyperreflexia (pronounced in the lower extremities), and a coarse resting tremor. What is the most appropriate immediate management?

A

Switch sertraline to venlafaxine and administer high-dose intramuscular tramadol for ongoing analgesic control

B

Stop sertraline and tramadol, provide monitored supportive care, cool actively and titrate a benzodiazepine for agitation

C

Administer intravenous dantrolene and oral bromocriptine while continuing the patient's current psychiatric medications

D

Prescribe oral procyclidine and reassure the patient that these symptoms represent an acute extrapyramidal dystonic reaction

Test Your Knowledge

A 42-year-old man with Bipolar I Disorder has been maintained on lithium carbonate 800 mg at bedtime for the past 3 years with excellent mood stability. Ten days ago, he developed a painful flare of knee osteoarthritis and was started on naproxen 500 mg twice daily by his orthopaedic surgeon. Today, his partner brings him to the acute medical assessment unit because he is unsteady on his feet, speaks with slurred words, and has experienced persistent vomiting and loose watery stools for 48 hours. On examination, he is alert and oriented but has coarse bilateral hand tremors, ataxic gait, and dysarthric speech. His blood pressure is 108/64 mmHg and heart rate is 96 beats/min. Which of the following is the most appropriate next clinical step?

A

Increase the bedtime lithium dose to achieve a target serum trough concentration of 1.5 to 2.0 mmol/L and initiate a thiazide diuretic

B

Order an immediate urgent MRI of the brain and prescribe oral procyclidine for acute drug-induced parkinsonism

C

Withhold lithium immediately, obtain urgent serum lithium and renal function tests, and administer intravenous 0.9% sodium chloride rehydration

D

Transfer immediately for emergent haemodialysis prior to drawing preliminary blood samples or obtaining electrolyte results

Test Your Knowledge

A 28-year-old primiparous woman presents to the maternity hospital day assessment service 6 days following an uncomplicated spontaneous vaginal delivery. Her husband reports that she has not slept for more than 2 hours in total over the last 3 days, yet she insists she has boundless energy and has been furiously organizing nursery furniture through the night. During the interview, she speaks with rapid, pressured speech, appears perplexed, and displays sudden shifts from tearfulness to expansive laughter. She confides to the doctor that she heard whispering voices coming from the baby's monitor telling her that the infant has been marked by evil spirits and that she must perform an emergency purification ritual to cleanse the child. What is the most appropriate management plan?

A

Arrange immediate emergency psychiatric assessment and admission planning, with close supervision and safe infant care

B

Reassure the mother that she is experiencing common postpartum blues that will resolve spontaneously within two weeks

C

Commence high-dose fluoxetine monotherapy and discharge home with community public health nurse review in four weeks

D

Initiate sodium valproate monotherapy and recommend continuing exclusive breastfeeding

Sections you finish are checked off in the contents.